This is a news story, published by ScienceDaily, that relates primarily to Duchenne news.
For more Duchenne news, you can click here:
more Duchenne newsFor more biology news, you can click here:
more biology newsFor more news from ScienceDaily, you can click here:
more news from ScienceDailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
muscular dystrophies 2B. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest rare muscle disorders news, muscular dystrophy news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Human LGMD2B Skeletal MuscleScienceDaily
•75% Informative
Lab-grown muscles reveal mysteries of rare muscle diseases called dysferlinopathy or limb girdle muscular dystrophies 2B.
LGMD2B affects only about eight people per million around the world.
The research revealed the biological mechanisms underlying the disease and showed that a combination of existing treatments could alleviate its symptoms.
Two drug candidates to potentially treat Duchenne muscular dystrophy have not been tested in humans.
One called dantrolene is supposed to stop calcium from leaking from muscle cells' reservoirs.
The second , called vamorolone, was recently approved for use with patients.
VR Score
82
Informative language
86
Neutral language
52
Article tone
semi-formal
Language
English
Language complexity
62
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links